Table 3. Haplotype analysis for NOD2 SNPs in the CD patient cohort.

NOD2 haplotypes	p-value	OR	CI lower	CI upper
rs2066843-rs2066844	1.31×10−8
TT	1.34×10−5	1.94	1.81	2.08
TC	3.09×10−4	1.34	1.28	1.40
CC	1.72×10−8	0.65	0.63	0.66
rs2066844-rs2066845	7.94×10−8
CC	3.25×10−3	1.80	1.58	2.06
TG	3.80×10−6	1.89	1.78	2.00
CG	1.08×10−8	0.52	0.50	0.54
rs2066845-rs2066847	1.09×10−18
GC	6.88×10−17	4.06	3.90	4.22
CX	6.67×10−3	1.74	1.50	2.02
GX	4.38×10−20	0.32	0.31	0.33
rs2066847-rs2076756	2.48×10−15
CG	2.88×10−14	3.84	3.67	4.02
XG	3.31×10−1	1.09	0.91	1.30
XA	2.35×10−9	0.62	0.61	0.64
rs2066843-rs2066844-rs2066845	5.94×10−10
TCC	1.16×10−3	1.90	1.69	2.14
TTG	8.40×10−7	2.01	1.90	2.13
TCG	2.64×10−2	1.21	1.12	1.31
CCG	9.68×10−10	0.62	0.61	0.64
rs2066844-rs2066845-rs2066847	8.22×10−24
CGC	5.84×10−17	4.07	3.91	4.23
CCX	1.08×10−2	1.70	1.45	1.99
TGX	3.59×10−6	1.89	1.78	2.00
CGX	4.19×10−26	0.37	0.36	0.37
rs2066845-rs2066847-rs2076756	2.48×10−15
GCG	5.41×10−17	4.09	3.93	4.25
CXG	1.04×10−3	1.94	1.72	2.19
GXG	3.47×10−1	0.92	0.76	1.11
GXA	3.89×10−12	0.59	0.57	0.60
rs2066843-rs2066844-rs2066845-rs2066847	1.60×10−23
TCGC	4.10×10−17	4.28	4.11	4.46
TCCX	1.18×10−3	1.90	1.69	2.14
TTGX	8.51×10−7	1.99	1.88	2.10
TCGX	2.32×10−5	0.66	0.63	0.69
CCGX	8.57×10−13	0.59	0.58	0.60
rs2066844-rs2066845-rs2066847-rs2076756	1.14×10−23
CGCG	5.20×10−17	4.04	3.89	4.20
CCXG	1.10×10−3	1.93	1.71	2.18
TGXG	4.75×10−7	2.06	1.95	2.18
CGXG	1.24×10−5	0.642	0.61	0.67
CGXA	7.82×10−13	0.59
rs2066843-rs2066844-rs2066845-rs2066847-rs2076756	1.43×10−21
TCGCG	6.33×10−17	4.18	4.02	4.35
TCCXG	1.07×10−3	1.93	1.71	2.18
TTGXG	6.00×10−7	2.05	1.94	2.17
TCGXG	9.42×10−5	0.67	0.64	0.71
TCGXA	6.48×10−2	0.576	0.42	0.79
CCGXA	2.01×10−11	0.61	0.60	0.63

Omnibus as well as individual p-values are presented.